Hepatocellular carcinoma continues to pose a diagnostic challenge, particularly in the setting of underlying pathomorphological changes in the liver due to cirrhosis, steatosis, or steatohepatitis.
Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with ...
In part 4 of our interview, we learn more about nipocalimab’s safety profile and how this investigative agent might address ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback